The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.
Identifieur interne : 000718 ( Main/Exploration ); précédent : 000717; suivant : 000719The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.
Auteurs : Attila Önmez [Turquie] ; Zerrin Gams Zkan [Turquie] ; Eyma Özdemir [Turquie] ; Enis Kesikba [Turquie] ; Feyzi Gökosmano Lu [Turquie] ; Serkan Torun [Turquie] ; Hakan Cinemre [Turquie]Source :
- Diabetes & metabolic syndrome [ 1878-0334 ]
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Diabète de type 2 (sang), Diabète de type 2 (épidémiologie), Femelle (MeSH), Glycémie (métabolisme), Humains (MeSH), Indice glycémique (physiologie), Mâle (MeSH), Prise de poids (physiologie), Quarantaine (tendances), Sujet âgé (MeSH), Turquie (épidémiologie), Études de suivi (MeSH), Études rétrospectives (MeSH).
- MESH :
- métabolisme : Glycémie.
- physiologie : Indice glycémique, Prise de poids.
- sang : Diabète de type 2.
- tendances : Quarantaine.
- épidémiologie : Diabète de type 2, Turquie.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Mâle, Sujet âgé, Études de suivi, Études rétrospectives.
- Wicri :
- geographic : Turquie.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Blood Glucose (metabolism), COVID-19 (blood), COVID-19 (epidemiology), Diabetes Mellitus, Type 2 (blood), Diabetes Mellitus, Type 2 (epidemiology), Female (MeSH), Follow-Up Studies (MeSH), Glycemic Index (physiology), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Quarantine (trends), Retrospective Studies (MeSH), Turkey (epidemiology), Weight Gain (physiology).
- MESH :
- chemical , metabolism : Blood Glucose.
- geographic , epidemiology : Turkey.
- blood : COVID-19, Diabetes Mellitus, Type 2.
- epidemiology : COVID-19, Diabetes Mellitus, Type 2.
- physiology : Glycemic Index, Weight Gain.
- trends : Quarantine.
- Adult, Aged, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies.
Abstract
BACKGROUND AND AIMS
A national lockdown to prevent the spread of coronavirus disease (COVID-19) in Turkey was introduced in March 2020. We think that lockdowns may lead to weight gain and worsening of glycemic parameters in patients with type 2 diabetes mellitus (DM). The purpose of this study was to investigate how type 2 DM patients were affected by the lockdown.
METHOD
Type 2 DM patients unable to attend regular follow-ups due to lockdown over a 75-day period between March and June 2020 and who again attended polyclinic follow-up when the lockdown was lifted were included in the study. These patients' glycemic control and weight status were compared with the pre-lockdown period. In addition, patients' general habits, and adherence to diet and exercise were evaluated, while their general health was assessed using the Short-Form 36-item survey.
RESULT
The research involved 101 type 2 DM patients, 57 men (56.5%) and 44 women (44.5%), with a mean age of 55 ± 13. Patients' mean pre-lockdown weight was 84.7 ± 16.4 kg, rising to 85.5 ± 16.8 kg post-lockdown, although the increase was not statistically significant (p = 0.781). In terms of glycemic parameters, Hba1c rose from 7.67 ± 1.76 to 8.11 ± 2.48, and fasting glucose from 157.9 (83-645) mg/dl to 163.2 (84-550) mg/dl, none of which were statistically significant (p = 0.253, p = 0.079, respectively).
CONCLUSION
In addition to weight gain among type 2 DM patients during the Covid 19 lockdown, statistically insignificant increases were also observed in such glycemic parameters. This was a small sample and further studies with larger sample are needed.
DOI: 10.1016/j.dsx.2020.10.007
PubMed: 33059299
PubMed Central: PMC7548075
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.</title><author><name sortKey="Onmez, Attila" sort="Onmez, Attila" uniqKey="Onmez A" first="Attila" last="Önmez">Attila Önmez</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: attilaonmez@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Gams Zkan, Zerrin" sort="Gams Zkan, Zerrin" uniqKey="Gams Zkan Z" first="Zerrin" last="Gams Zkan">Zerrin Gams Zkan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: zgamsizkan@yahoo.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Family Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Ozdemir, Eyma" sort="Ozdemir, Eyma" uniqKey="Ozdemir " first=" Eyma" last="Özdemir"> Eyma Özdemir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: seyma_ozdemir171@hotmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Kesikba, Enis" sort="Kesikba, Enis" uniqKey="Kesikba E" first="Enis" last="Kesikba">Enis Kesikba</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: dreniskesikbas@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Gokosmano Lu, Feyzi" sort="Gokosmano Lu, Feyzi" uniqKey="Gokosmano Lu F" first="Feyzi" last="Gökosmano Lu">Feyzi Gökosmano Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, Samsun Medicana Hospital, Samsun, Turkey. Electronic address: gokosmanoglu@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Endocrinology, Samsun Medicana Hospital, Samsun</wicri:regionArea><wicri:noRegion>Samsun</wicri:noRegion></affiliation></author><author><name sortKey="Torun, Serkan" sort="Torun, Serkan" uniqKey="Torun S" first="Serkan" last="Torun">Serkan Torun</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: serkantorundr@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Cinemre, Hakan" sort="Cinemre, Hakan" uniqKey="Cinemre H" first="Hakan" last="Cinemre">Hakan Cinemre</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Sakarya University Medical Faculty, Sakarya, Turkey. Electronic address: cinemreh@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Sakarya University Medical Faculty, Sakarya</wicri:regionArea><wicri:noRegion>Sakarya</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Nov-Dec</date><idno type="RBID">pubmed:33059299</idno><idno type="pmid">33059299</idno><idno type="doi">10.1016/j.dsx.2020.10.007</idno><idno type="pmc">PMC7548075</idno><idno type="wicri:Area/Main/Corpus">001243</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001243</idno><idno type="wicri:Area/Main/Curation">001243</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001243</idno><idno type="wicri:Area/Main/Exploration">001243</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.</title><author><name sortKey="Onmez, Attila" sort="Onmez, Attila" uniqKey="Onmez A" first="Attila" last="Önmez">Attila Önmez</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: attilaonmez@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Gams Zkan, Zerrin" sort="Gams Zkan, Zerrin" uniqKey="Gams Zkan Z" first="Zerrin" last="Gams Zkan">Zerrin Gams Zkan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Family Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: zgamsizkan@yahoo.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Family Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Ozdemir, Eyma" sort="Ozdemir, Eyma" uniqKey="Ozdemir " first=" Eyma" last="Özdemir"> Eyma Özdemir</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: seyma_ozdemir171@hotmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Kesikba, Enis" sort="Kesikba, Enis" uniqKey="Kesikba E" first="Enis" last="Kesikba">Enis Kesikba</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: dreniskesikbas@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Gokosmano Lu, Feyzi" sort="Gokosmano Lu, Feyzi" uniqKey="Gokosmano Lu F" first="Feyzi" last="Gökosmano Lu">Feyzi Gökosmano Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, Samsun Medicana Hospital, Samsun, Turkey. Electronic address: gokosmanoglu@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Endocrinology, Samsun Medicana Hospital, Samsun</wicri:regionArea><wicri:noRegion>Samsun</wicri:noRegion></affiliation></author><author><name sortKey="Torun, Serkan" sort="Torun, Serkan" uniqKey="Torun S" first="Serkan" last="Torun">Serkan Torun</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: serkantorundr@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Duzce University Medical Faculty, Duzce</wicri:regionArea><wicri:noRegion>Duzce</wicri:noRegion></affiliation></author><author><name sortKey="Cinemre, Hakan" sort="Cinemre, Hakan" uniqKey="Cinemre H" first="Hakan" last="Cinemre">Hakan Cinemre</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Sakarya University Medical Faculty, Sakarya, Turkey. Electronic address: cinemreh@gmail.com.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Internal Medicine, Sakarya University Medical Faculty, Sakarya</wicri:regionArea><wicri:noRegion>Sakarya</wicri:noRegion></affiliation></author></analytic><series><title level="j">Diabetes & metabolic syndrome</title><idno type="eISSN">1878-0334</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Blood Glucose (metabolism)</term><term>COVID-19 (blood)</term><term>COVID-19 (epidemiology)</term><term>Diabetes Mellitus, Type 2 (blood)</term><term>Diabetes Mellitus, Type 2 (epidemiology)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>Glycemic Index (physiology)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Quarantine (trends)</term><term>Retrospective Studies (MeSH)</term><term>Turkey (epidemiology)</term><term>Weight Gain (physiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Diabète de type 2 (sang)</term><term>Diabète de type 2 (épidémiologie)</term><term>Femelle (MeSH)</term><term>Glycémie (métabolisme)</term><term>Humains (MeSH)</term><term>Indice glycémique (physiologie)</term><term>Mâle (MeSH)</term><term>Prise de poids (physiologie)</term><term>Quarantaine (tendances)</term><term>Sujet âgé (MeSH)</term><term>Turquie (épidémiologie)</term><term>Études de suivi (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Blood Glucose</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Turkey</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>COVID-19</term><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>COVID-19</term><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycémie</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Indice glycémique</term><term>Prise de poids</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Glycemic Index</term><term>Weight Gain</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Diabète de type 2</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Quarantaine</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Quarantine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Diabète de type 2</term><term>Turquie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Turquie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND AND AIMS</b></p><p>A national lockdown to prevent the spread of coronavirus disease (COVID-19) in Turkey was introduced in March 2020. We think that lockdowns may lead to weight gain and worsening of glycemic parameters in patients with type 2 diabetes mellitus (DM). The purpose of this study was to investigate how type 2 DM patients were affected by the lockdown.</p></div><div type="abstract" xml:lang="en"><p><b>METHOD</b></p><p>Type 2 DM patients unable to attend regular follow-ups due to lockdown over a 75-day period between March and June 2020 and who again attended polyclinic follow-up when the lockdown was lifted were included in the study. These patients' glycemic control and weight status were compared with the pre-lockdown period. In addition, patients' general habits, and adherence to diet and exercise were evaluated, while their general health was assessed using the Short-Form 36-item survey.</p></div><div type="abstract" xml:lang="en"><p><b>RESULT</b></p><p>The research involved 101 type 2 DM patients, 57 men (56.5%) and 44 women (44.5%), with a mean age of 55 ± 13. Patients' mean pre-lockdown weight was 84.7 ± 16.4 kg, rising to 85.5 ± 16.8 kg post-lockdown, although the increase was not statistically significant (p = 0.781). In terms of glycemic parameters, Hba1c rose from 7.67 ± 1.76 to 8.11 ± 2.48, and fasting glucose from 157.9 (83-645) mg/dl to 163.2 (84-550) mg/dl, none of which were statistically significant (p = 0.253, p = 0.079, respectively).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>In addition to weight gain among type 2 DM patients during the Covid 19 lockdown, statistically insignificant increases were also observed in such glycemic parameters. This was a small sample and further studies with larger sample are needed.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33059299</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0334</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><MedlineDate>2020 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>Diabetes & metabolic syndrome</Title><ISOAbbreviation>Diabetes Metab Syndr</ISOAbbreviation></Journal><ArticleTitle>The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.</ArticleTitle><Pagination><MedlinePgn>1963-1966</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1871-4021(20)30395-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dsx.2020.10.007</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">A national lockdown to prevent the spread of coronavirus disease (COVID-19) in Turkey was introduced in March 2020. We think that lockdowns may lead to weight gain and worsening of glycemic parameters in patients with type 2 diabetes mellitus (DM). The purpose of this study was to investigate how type 2 DM patients were affected by the lockdown.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Type 2 DM patients unable to attend regular follow-ups due to lockdown over a 75-day period between March and June 2020 and who again attended polyclinic follow-up when the lockdown was lifted were included in the study. These patients' glycemic control and weight status were compared with the pre-lockdown period. In addition, patients' general habits, and adherence to diet and exercise were evaluated, while their general health was assessed using the Short-Form 36-item survey.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">The research involved 101 type 2 DM patients, 57 men (56.5%) and 44 women (44.5%), with a mean age of 55 ± 13. Patients' mean pre-lockdown weight was 84.7 ± 16.4 kg, rising to 85.5 ± 16.8 kg post-lockdown, although the increase was not statistically significant (p = 0.781). In terms of glycemic parameters, Hba1c rose from 7.67 ± 1.76 to 8.11 ± 2.48, and fasting glucose from 157.9 (83-645) mg/dl to 163.2 (84-550) mg/dl, none of which were statistically significant (p = 0.253, p = 0.079, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In addition to weight gain among type 2 DM patients during the Covid 19 lockdown, statistically insignificant increases were also observed in such glycemic parameters. This was a small sample and further studies with larger sample are needed.</AbstractText><CopyrightInformation>Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Önmez</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: attilaonmez@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamsızkan</LastName><ForeName>Zerrin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: zgamsizkan@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Şeyma</ForeName><Initials>Ş</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: seyma_ozdemir171@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesikbaş</LastName><ForeName>Enis</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: dreniskesikbas@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gökosmanoğlu</LastName><ForeName>Feyzi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Samsun Medicana Hospital, Samsun, Turkey. Electronic address: gokosmanoglu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torun</LastName><ForeName>Serkan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey. Electronic address: serkantorundr@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinemre</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Sakarya University Medical Faculty, Sakarya, Turkey. Electronic address: cinemreh@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Diabetes Metab Syndr</MedlineTA><NlmUniqueID>101462250</NlmUniqueID><ISSNLinking>1871-4021</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038321" MajorTopicYN="N">Glycemic Index</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid 19</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Lockdown</Keyword><Keyword MajorTopicYN="N">Outbreak</Keyword><Keyword MajorTopicYN="N">SARS-cov 2</Keyword><Keyword MajorTopicYN="N">SF-36</Keyword></KeywordList><CoiStatement>Declaration of competing interest All authors have no conflicts of interest and source of funding.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>09</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>15</Day><Hour>20</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33059299</ArticleId><ArticleId IdType="pii">S1871-4021(20)30395-7</ArticleId><ArticleId IdType="doi">10.1016/j.dsx.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7548075</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 2020 Aug;43(8):e88-e89</Citation><ArticleIdList><ArticleId IdType="pubmed">32540921</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2020 Aug;166:108307</Citation><ArticleIdList><ArticleId IdType="pubmed">32650036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1563-1569</Citation><ArticleIdList><ArticleId IdType="pubmed">32853901</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr J. 2004 Aug;51(4):407-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15351797</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):351-354</Citation><ArticleIdList><ArticleId IdType="pubmed">32311652</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1992 Jun;30(6):473-83</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323</Citation><ArticleIdList><ArticleId IdType="pubmed">32298984</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2020 May 14;55(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2020 Aug 04;12(8):</Citation><ArticleIdList><ArticleId IdType="pubmed">32759636</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2015 Feb 19;15:163</Citation><ArticleIdList><ArticleId IdType="pubmed">25884807</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2020 Jul 07;12(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">32645970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ment Health Fam Med. 2008 Jun;5(2):85-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22477853</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2020 Sep;167:108354</Citation><ArticleIdList><ArticleId IdType="pubmed">32739380</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2020 Jun;22(6):462-467</Citation><ArticleIdList><ArticleId IdType="pubmed">32421355</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 1993 Oct;10(8):774-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8261762</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212</Citation><ArticleIdList><ArticleId IdType="pubmed">32172175</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Ther. 2020 May 11;:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">32395187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Apr 1;40(7):990-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15824991</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Onmez, Attila" sort="Onmez, Attila" uniqKey="Onmez A" first="Attila" last="Önmez">Attila Önmez</name></noRegion><name sortKey="Cinemre, Hakan" sort="Cinemre, Hakan" uniqKey="Cinemre H" first="Hakan" last="Cinemre">Hakan Cinemre</name><name sortKey="Gams Zkan, Zerrin" sort="Gams Zkan, Zerrin" uniqKey="Gams Zkan Z" first="Zerrin" last="Gams Zkan">Zerrin Gams Zkan</name><name sortKey="Gokosmano Lu, Feyzi" sort="Gokosmano Lu, Feyzi" uniqKey="Gokosmano Lu F" first="Feyzi" last="Gökosmano Lu">Feyzi Gökosmano Lu</name><name sortKey="Kesikba, Enis" sort="Kesikba, Enis" uniqKey="Kesikba E" first="Enis" last="Kesikba">Enis Kesikba</name><name sortKey="Ozdemir, Eyma" sort="Ozdemir, Eyma" uniqKey="Ozdemir " first=" Eyma" last="Özdemir"> Eyma Özdemir</name><name sortKey="Torun, Serkan" sort="Torun, Serkan" uniqKey="Torun S" first="Serkan" last="Torun">Serkan Torun</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000718 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000718 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= LockdownV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33059299
|texte= The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33059299" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LockdownV1
| This area was generated with Dilib version V0.6.38. |  |